Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11059911 Sequence symmetric modified IgG4 bispecific antibodies
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
January 8, 2019
Date of Patent
July 13, 2021
Patent Application Number
16242378
Patent Citations
US Patent 10233251 Antibody therapeutics that bind CD137
US Patent 10563966 Vibratory powder trickler
US Patent 10221251 Sequence symmetric modified IGG4 bispecific antibodies
US Patent 10259881 Antibody therapeutics that bind CD137
Patent Citations Received
US Patent 12129294 Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies
0
US Patent 12122826 Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11059911
Patent Primary Examiner
Lynn A Bristol
Find more entities like US Patent 11059911 Sequence symmetric modified IgG4 bispecific antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE